Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee advances bill to expand insurer coverage for biomarker testing after extensive patient testimony
Summary
Assembly Bill 4163, which would require health insurers to cover medically appropriate biomarker testing, was reported out of the Appropriations Committee following detailed testimony from clinicians, patient advocates and survivors who described diagnostic and treatment benefits and inequities in access.
The Assembly Appropriations Committee on Dec. 16 reported Assembly Bill 4163 (first reprint), which would require health insurers to provide coverage for biomarker testing when medically appropriate. Witnesses described clinical benefits, access disparities and potential cost savings.
Doreen Monks, a volunteer policy advocate for the Greater New Jersey Chapter of the Alzheimer's Association and a retired neuroscience nurse practitioner, told the committee her experience with an early‑onset…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
